Maj J, Rogóz Z, Skuza G
Institute of Pharmacology, Polish Academy of Sciences, Kraków.
Pol J Pharmacol Pharm. 1992 May-Jun;44(3):217-26.
We found previously that combined administration of imipramine, citalopram and, to a lesser extent, mianserin with MK-801, a non-competitive NMDA receptor antagonist, reduced the immobility time in the forced swimming test in rats more potently than administration of the antidepressant or MK-801 alone. In present paper we examined the effect of other antidepressants in this model. (+)-Oxaprotiline and (-)-oxaprotiline which, when given alone, showed a weak positive effect, increased the action of MK-801. Fluoxetine, inactive when given alone, markedly increased the effect of MK-801. Moreover, the positive effect after combined treatment was found in the experiments in which antidepressants and MK-801 given separately were inactive. A reduction in the immobility time was also observed in those experimental paradigms in which the locomotor activity was not increased. The effects of combined treatment with the antidepressants studied + MK-801 were antagonized by haloperidol, but not by prazosin. The obtained results indicate that mainly a dopamine mechanism seems to be involved in the synergistic action of MK-801 and the antidepressants in the forced swimming test.
我们先前发现,将丙咪嗪、西酞普兰以及(程度稍轻的)米安色林与非竞争性NMDA受体拮抗剂MK-801联合给药,比单独给予抗抑郁药或MK-801更有效地缩短了大鼠强迫游泳试验中的不动时间。在本论文中,我们研究了其他抗抑郁药在该模型中的作用。单独给药时显示出微弱阳性作用的(+)-奥沙普替林和(-)-奥沙普替林增强了MK-801的作用。单独给药时无活性的氟西汀显著增强了MK-801的作用。此外,在单独给予抗抑郁药和MK-801均无活性的实验中,联合治疗后也发现了阳性作用。在那些运动活性未增加的实验范式中也观察到了不动时间的缩短。所研究的抗抑郁药与MK-801联合治疗的作用被氟哌啶醇拮抗,但未被哌唑嗪拮抗。所得结果表明,在强迫游泳试验中,MK-801与抗抑郁药的协同作用主要似乎涉及多巴胺机制。